Patents by Inventor Brandy Weidow

Brandy Weidow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Soluble fibrin inhibitory peptides and uses thereof
    Patent number: 9777054
    Abstract: The present invention demonstrated that soluble fibrin binds to both Mac-1 and ICAM-1-expressing cells and inhibited adherence of these cells and immune cytotoxicity, thus inducing immune suppression in cancer. Additionally, the present invention also demonstrated that soluble fibrin enhanced metastasis in an in vivo model. Furthermore, the present invention demonstrated the utility of specific peptides that block binding of soluble fibrin to these cells as therapeutic agents in cancer progression and metastasis. It is further contemplated that these peptides can also be used to treat other diseases such as cardiovascular disease, arthritis and in many inflammatory responses where there is increased levels of soluble fibrin.
    Type: Grant
    Filed: August 23, 2006
    Date of Patent: October 3, 2017
    Assignee: ENSION INC.
    Inventors: John Biggerstaff, Brandy Weidow
  • Soluble fibrin inhibitory peptides and uses thereof
    Publication number: 20070060522
    Abstract: The present invention demonstrated that soluble fibrin binds to both Mac-1 and ICAM-1-expressing cells and inhibited adherence of these cells and immune cytotoxicity, thus inducing immune suppression in cancer. Additionally, the present invention also demonstrated that soluble fibrin enhanced metastasis in an in vivo model. Furthermore, the present invention demonstrated the utility of specific peptides that block binding of soluble fibrin to these cells as therapeutic agents in cancer progression and metastasis. It is further contemplated that these peptides can also be used to treat other diseases such as cardiovascular disease, arthritis and in many inflammatory responses where there is increased levels of soluble fibrin.
    Type: Application
    Filed: August 23, 2006
    Publication date: March 15, 2007
    Inventors: John Biggerstaff, Brandy Weidow